Extraintestinal Cutaneous Manifestations in Inflammatory Bowel Disease Among Non-White Patients

作者：Shaina Ailawadi, Sahil Sethi, Abdullah Mahmood, Elleson Harper, Jaime Perez, Gregory W. Cooper, Preetika Sinh, V Nguyen, J. Lawrence Katz, Fabio Cominelli, Miguel Regueiro, Emad Mansoor · 发表于：Journal of Clinical Gastroenterology · 年份：2026 · DOI：10.1097/mcg.0000000000002325 · 研究领域：Inflammatory Bowel Disease、Autoimmune and Inflammatory Disorders、Microscopic Colitis

BACKGROUND: The presence of extraintestinal manifestations with cutaneous diseases in patients with inflammatory bowel disease (IBD) can pose significant complications. Though the prevalence of IBD has been increasing in racial and ethnic minority groups, most literature has characterized several cutaneous manifestations (CM) of IBD in patients of white skin, with a lack of studies describing these complications in patients with other skin tones. METHODS: Our study aimed to determine the rates of various CM of IBD in skin of color using a health care database to identify white and non-white patients with a diagnosis of IBD who were prescribed at least one IBD-specific medication or advanced therapy. RESULTS: Of the total IBD patients, after propensity score matching there were 35,624 patients identified in both the white and non-white cohorts. Among non-white patients, there was a >2-fold odds of developing hidradenitis suppurativa and increased odds of vitiligo. Psoriasis, herpes zoster, and leukocytoclastic vasculitis exhibited a decreased association in non-white patients. There was no difference in erythema nodosum, pyoderma gangrenosum, oral aphthae, Sweet syndrome, and acquired epidermolysis bullosa. CONCLUSION: With the rise of IBD in non-white populations, the representation of CM of IBD in this population is significantly limited, underrecognized, and thus undertreated. Our results reveal increased prevalence of several CM in the non-white IBD patient population. Rec...